Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › micafungin

micafungin

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of micafungin

5 trials tracked of micafungin: 3 in phase 3 or 4.

5Trials tracked
3Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 3 Phase 2 2
  1. Phase 4 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome Completed
  2. Phase 4 Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers Completed
  3. Phase 4 Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins Completed
  4. Phase 2 Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis Completed
  5. Phase 2 Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Combination voriconazole and micafungin improved a boy with CGD and invasive Aspergillus lentulus infection
Rheumatology Guideline
Combination voriconazole and micafungin improved a boy with CGD and invasive Aspergillus lentulus infection Combination antifungals helped a boy with rare lung infection before transplant
This guideline discusses a case report of a boy with chronic granulomatous disease and invasive pulmonary Aspergillus lentulus infection. Th…
A boy with chronic granulomatous disease improved on two antifungal drugs before a pending stem cell transplant.
Frontiers Jun 2, 2026
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients
Diabetes & Endocrinology Meta-analysis
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients Antifungal resistance high in diabetic foot ulcers
This systematic review and meta-analysis evaluated antifungal resistance in patients with diabetic foot ulcers.
Many diabetic foot ulcer infections resist common antifungals, especially nystatin and itraconazole.
May 1, 2026